A detailed history of Aisling Capital Management LP transactions in Viracta Therapeutics, Inc. stock. As of the latest transaction made, Aisling Capital Management LP holds 288,571 shares of VIRX stock, worth $72,142. This represents 0.03% of its overall portfolio holdings.

Number of Shares
288,571
Previous 288,571 -0.0%
Holding current value
$72,142
Previous $155,000 57.42%
% of portfolio
0.03%
Previous 0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021

BUY
$7.55 - $12.95 $2.18 Million - $3.74 Million
288,571 New
288,571 $3.27 Million

Others Institutions Holding VIRX

About Viracta Therapeutics, Inc.


  • Ticker VIRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,558,200
  • Market Cap $9.39M
  • Description
  • Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...
More about VIRX
Track This Portfolio

Track Aisling Capital Management LP Portfolio

Follow Aisling Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aisling Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Aisling Capital Management LP with notifications on news.